All news

All volunteers develop coronavirus immunity after Russian vaccine trial

Russian scientists would release all their findings in August

MOSCOW, July 31. /TASS/. The vaccine against the novel coronavirus, developed by Russian scientists, has created immunity in 100% of volunteers who took part in its trials, the head of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said in a CNN interview on Friday.

According to the Russian official, 100% of volunteers developed immunity on the 21st day after receiving the first dose. Their immunity doubled after the second injection.

"I can tell you, from first and second phase we have hundred percent of people developing immunity after day 21. It doubles after the second shot. Hundred percent of animals were also protected [against the novel coronavirus]," Dmitriev said.

When asked when Russia would publish its findings, the RDIF head replied that all information would be released in August.

"We selected the safest approach, it has been extensively tested not only now, but also in Ebola vaccine we got approved, in MERS vaccine that was approved," he went on. "We chose the safest possible delivery mechanism."

According to Dmitriev, more than 20 nations have demonstrated interest in buying Russia-developed anti-coronavirus vaccine.

"More than 20 countries approached us on our vaccine," he said, adding that five nations were planning to take part in the production of the Russian anti-coronavirus vaccine.

Russian Deputy Prime Minister Tatiana Golikova said earlier it was planned to launch mass production of a vaccine developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian health ministry in September 2020. Apart from that, in her words, the first batch of another vaccine, developed by the Russian sanitary watchdog’s Vektor Research Center, would be manufactured in October 2020.